We found a small but statistically significant reduction in the linoleic acid concentration of white blood cells and platelets in MS patients. The percent linoleic acid concentration (mean +/- S.D.) in the white blood cells if 24 MS patients was 8.8 +/- 1.8% as compared with 11.4 +/- 4.9 in 24 age and sex-matched controls (p less than 0.05). Platelet levels were 8.5 +/- 2.4% and 10.6 +/- 3.8% respectively (P less than 0.05). Serum linoleic acid levels were not significantly different in the two groups. The possible role of linoleic acid in the pathogenesis of MS has yet to be defined
Jean-Martin Charcot has first described multiple sclerosis (MS) as a disease of the central nervous ...
We determined serum levels of ascorbic acid, beta-carotene, retinol and alpha tocopherol and lipid p...
Bioactive lipids contribute to the pathophysiology of multiple sclerosis. Here, we show that lysopho...
The percentage composition of the free and esteri-fied fatty acids in the total lipid extracts of sa...
Background: Reports on fatty acids levels in multiple sclerosis remain inconclusive. Objective: To d...
BACKGROUND: There is no good explanation why a proportion of patients with multiple sclerosis (MS) h...
Although much work has been done on the levels of cholesterol, cholesterol esters, and the various p...
The aim of this study was to investigate whether blood cell membrane monounsaturated fatty acids wer...
Multiple Sclerosis (MS) patients present a decrease of antioxidants and neuroprotective and immunore...
A decrease of antioxidants, of neuroprotective and immunoregulatory vitamins and an increase of tota...
In clinical practice it is not uncommon for patients with adrenomyeloneuropathy or female carriers o...
Background: multiple sclerosis (MS) is a CNS-specific demyelinating disease with most patients demon...
fatty acid and lipid profiles in plasma and erythrocytes in patients with multiple sclerosis1
SUMMARY The absolute electrophoretic mobility of red blood cells was examined before and after the a...
Multiple Sclerosis (MS) is a neurodegenerative autoimmune demyelinating disease affecting young adul...
Jean-Martin Charcot has first described multiple sclerosis (MS) as a disease of the central nervous ...
We determined serum levels of ascorbic acid, beta-carotene, retinol and alpha tocopherol and lipid p...
Bioactive lipids contribute to the pathophysiology of multiple sclerosis. Here, we show that lysopho...
The percentage composition of the free and esteri-fied fatty acids in the total lipid extracts of sa...
Background: Reports on fatty acids levels in multiple sclerosis remain inconclusive. Objective: To d...
BACKGROUND: There is no good explanation why a proportion of patients with multiple sclerosis (MS) h...
Although much work has been done on the levels of cholesterol, cholesterol esters, and the various p...
The aim of this study was to investigate whether blood cell membrane monounsaturated fatty acids wer...
Multiple Sclerosis (MS) patients present a decrease of antioxidants and neuroprotective and immunore...
A decrease of antioxidants, of neuroprotective and immunoregulatory vitamins and an increase of tota...
In clinical practice it is not uncommon for patients with adrenomyeloneuropathy or female carriers o...
Background: multiple sclerosis (MS) is a CNS-specific demyelinating disease with most patients demon...
fatty acid and lipid profiles in plasma and erythrocytes in patients with multiple sclerosis1
SUMMARY The absolute electrophoretic mobility of red blood cells was examined before and after the a...
Multiple Sclerosis (MS) is a neurodegenerative autoimmune demyelinating disease affecting young adul...
Jean-Martin Charcot has first described multiple sclerosis (MS) as a disease of the central nervous ...
We determined serum levels of ascorbic acid, beta-carotene, retinol and alpha tocopherol and lipid p...
Bioactive lipids contribute to the pathophysiology of multiple sclerosis. Here, we show that lysopho...